Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation Baluk, P.; Tammela, T.; Ator, E.; Lyubynska, N.; Achen, M.G.; Hicklin, D.J.; Jeltsch, M.; Petrova, T.V.; Pytowski, B.; Stacker, S.A.; Yla-Herttuala, S.; Jackson, D.G.; Alitalo, K.; McDonald, D.M. , J Clin Invest, Volume 115, Issue 2, Cardiovascular Research Institute, Comprehensive Cancer Center, and Department of Anatomy, UCSF, San Francisco, California 94143, USA, p.247-57, (2005) Abstract

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice Veikkola, T.; Jussila, L.; Makinen, T.; Karpanen, T.; Jeltsch, M.; Petrova, T.V.; Kubo, H.; Thurston, G.; McDonald, D.M.; Achen, M.G.; Stacker, S.A.; Alitalo, K. , EMBO J, Volume 20, Issue 6, Molecular/Cancer Biology Laboratory and Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, PO Box 21 (Haartmaninkatu 3), 00014 Helsinki, Finland, p.1223-31, (2001) Abstract

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (F Achen, M.G.; Jeltsch, M.; Kukk, E.; Makinen, T.; Vitali, A.; Wilks, A.F.; Alitalo, K.; Stacker, S.A. , Proc Natl Acad Sci U S A, Volume 95, Issue 2, Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Victoria, Australia. Marc.achen@ludwig.edu.au, p.548-53, (1998) Abstract